TNF-ALPHA: A NEW VILLAIN IN GLAUCOMATOUS NEURODEGENERATION

M. B. Wax and G. Tezel

Department of Ophthalmology, Washington University School Medicine, USA

We have previously reported (Arch Ophthal 2000;118:666) that astroglia in the optic nerve head of glaucomatous eyes demonstrate increased expression of the pro-inflammatory cytokine tumor necrosis factor-alpha. Using a co-culture system, in which retinal ganglion cells and glial cells are grown on different layers, but share the same culture medium, we studied influences of glial cells on survival of retinal ganglion cells following exposure to different stress conditions typified by simulated ischemia and elevated hydrostatic pressure. Following exposure to these stressors, we observed that glial cells secreted TNF-alpha as well as other noxious agents such as nitric oxide into the co-culture media which facilitated apoptotic death of retinal ganglion cells as assessed by morphology, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and caspase activity. The glial origin of these noxious effects was confirmed by passive transfer experiments. Since elevated intraocular pressure and ischemia are two prominent stress factors identified in the eyes of patients with glaucoma, these findings reveal a novel glia-initiated pathogenic mechanism for retinal ganglion cell death in glaucoma. In addition, these findings suggest that inhibition of TNF-alpha released by activated glial cells may provide a novel therapeutic target for neuroprotection in the treatment of glaucomatous optic neuropathy.

(Supported by NIH RO-1 12314; Glaucoma Research Foundation, San Francisco, American Health Assistance Foundation, Glaucoma Foundation, NYC and Pharmacia)